(Total Views: 202)
Posted On: 01/24/2023 10:15:47 AM
Post# of 124603
$CGEM News Article - Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-978, a Novel T-Cell Engager for the Treatment of Relapsed/Refractory B-cell Non-Hodgkin Lymphoma https://marketwirenews.com/news-releases/cull...51779.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
